{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T16:42:56Z","timestamp":1777394576189,"version":"3.51.4"},"reference-count":38,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2011,5,1]],"date-time":"2011-05-01T00:00:00Z","timestamp":1304208000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,7,22]],"date-time":"2013-07-22T00:00:00Z","timestamp":1374451200000},"content-version":"vor","delay-in-days":813,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neuroscience Letters"],"published-print":{"date-parts":[[2011,5]]},"DOI":"10.1016\/j.neulet.2011.03.040","type":"journal-article","created":{"date-parts":[[2011,4,6]],"date-time":"2011-04-06T16:53:04Z","timestamp":1302108784000},"page":"63-66","source":"Crossref","is-referenced-by-count":13,"title":["Serotonin-1A receptors in the dorsal periaqueductal gray matter mediate the panicolytic-like effect of pindolol and paroxetine combination in the elevated T-maze"],"prefix":"10.1016","volume":"495","author":[{"given":"V\u00e2nia Ramos","family":"Sela","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carla","family":"Biesdorf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diego Henrique","family":"Ramos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"Jr.","given":"H\u00e9lio","family":"Zangrossi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frederico Guilherme","family":"Graeff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisabeth Aparecida","family":"Audi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.neulet.2011.03.040_bib0005","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1001\/archpsyc.1994.03950030084009","article-title":"Pindolol induces a rapid improvement of depressed patients treated with serotonin reuptake inhibitors","volume":"51","author":"Artigas","year":"1994","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.neulet.2011.03.040_bib0010","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/S0165-6147(00)01682-5","article-title":"How does pindolol improve antidepressant action?","volume":"22","author":"Artigas","year":"2001","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.neulet.2011.03.040_bib0015","doi-asserted-by":"crossref","first-page":"139","DOI":"10.2174\/138945006775515446","article-title":"Pindolol augmentation of antidepressant response","volume":"7","author":"Artigas","year":"2006","journal-title":"Curr. Drug Targets"},{"key":"10.1016\/j.neulet.2011.03.040_bib0020","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1176\/ajp.154.1.37","article-title":"Effect of pindolol in hastening response to fluoxetine in the treatment of major depression: a doubleblind, placebo-controlled trial","volume":"154","author":"Berman","year":"1997","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.neulet.2011.03.040_bib0025","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0893-133X(99)00036-6","article-title":"Serotonin and drug-induced therapeutic responses in major depression, obsessive\u2013compulsive and panic disorders","volume":"21","author":"Blier","year":"1999","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neulet.2011.03.040_bib0030","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0006-3223(00)01093-3","article-title":"Is the beneficial antidepressant effect of coadministration of pindolol really due to somatodendritic autoreceptor antagonism?","volume":"50","author":"Cremers","year":"2001","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neulet.2011.03.040_bib0035","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1007\/s00213-005-0189-y","article-title":"Effects of fluoxetine and buspirone on the panicolytic-like response induced by the activation of 5-HT1A and 5-HT2A receptors in the rat dorsal periaqueductal gray","volume":"183","author":"De Bortoli","year":"2006","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.neulet.2011.03.040_bib0040","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2009\/108135","article-title":"Panic disorder: is the PAG involved?","volume":"2009","author":"Del-Ben","year":"2009","journal-title":"Neural Plast."},{"key":"10.1016\/j.neulet.2011.03.040_bib0045","series-title":"Biol. Psychiatry","first-page":"879","article-title":"Animal models of anxiety disorders","author":"Graeff","year":"2002"},{"key":"10.1016\/j.neulet.2011.03.040_bib0050","first-page":"378","article-title":"Effect of sustained (\u00b1)pindolol administration on serotonin neurotransmission in rats","volume":"25","author":"Haddjeri","year":"2000","journal-title":"J. Psychiatry Neurosci."},{"key":"10.1016\/j.neulet.2011.03.040_bib0055","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1097\/00004714-200010000-00011","article-title":"Pindolol augmentation in patients with treatment-resistant panic disorder: a double-blind, placebo-controlled trial","volume":"20","author":"Hirschmann","year":"2000","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.neulet.2011.03.040_bib0060","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0014-2999(96)00779-0","article-title":"Raphe 5-HT1A autoreceptors, but not postsynaptic 5-HT1A receptors or betaadrenoceptors, restrain the citalopram-induced increase in extracellular 5-hydroxytryptamine in vivo","volume":"316","author":"Hjorth","year":"1996","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neulet.2011.03.040_bib0065","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1111\/j.1440-1819.2006.01512.x","article-title":"Comparison of venlafaxine extended release versus paroxetine for treatment of patients with generalized anxiety disorder","volume":"60","author":"Kim","year":"2006","journal-title":"Psychiatry Clin. Neurosci."},{"key":"10.1016\/j.neulet.2011.03.040_bib0070","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0893-133X(00)00187-1","article-title":"Differential occupancy of somatodendritic and postsynaptic 5HT1A receptors by pindolol: a dose-occupancy study with [11C]WAY 100635 and positron emission tomography in humans","volume":"24","author":"Martinez","year":"2001","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neulet.2011.03.040_bib0075","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1007\/s00210-002-0530-5","article-title":"Somatodendritic action of pindolol to attenuate the paroxetine-induced decrease in serotonin release from the rat ventral hippocampus: a microdialysis study","volume":"365","author":"Miguez","year":"2002","journal-title":"Naunyn. Schmiedebergs Arch. Pharmacol."},{"key":"10.1016\/j.neulet.2011.03.040_bib0080","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0091-3057(94)00402-5","article-title":"Role of 5-HT receptor subtypes in the modulation of dorsal periaqueductal gray generated aversion","volume":"52","author":"Nogueira","year":"1995","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neulet.2011.03.040_bib0085","series-title":"The Rat Brain in Stereotaxic Coordinates","author":"Paxinos","year":"2005"},{"key":"10.1016\/j.neulet.2011.03.040_bib0090","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1016\/S0140-6736(96)08007-5","article-title":"Randomised, double-blind, placebo-controlled trial of pindolol in combination with fluoxetine antidepressant treatment","volume":"349","author":"Perez","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/j.neulet.2011.03.040_bib0095","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1007\/s00213-005-0196-z","article-title":"5-HT1A and 5-HT2A receptors in the rat dorsal periaqueductal gray mediate the antipanic-like effect induced by the stimulation of serotonergic neurons in the dorsal raphe nucleus","volume":"183","author":"Pobbe","year":"2005","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.neulet.2011.03.040_bib0100","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1176\/appi.ajp.160.4.749","article-title":"Paroxetine treatment of generalized anxiety disorder: a double-blind, placebo-controlled study","volume":"160","author":"Rickels","year":"2003","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.neulet.2011.03.040_bib0105","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/0893-133X(95)00240-E","article-title":"Effect of pindolol on the function of pre- and postsynaptic 5-HTIA receptors: in vivo microdialysis and electrophysiological studies in the rat brain","volume":"15","author":"Romero","year":"1996","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neulet.2011.03.040_bib0110","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1007\/BF00428199","article-title":"Anti-aversive role of serotonin in the dorsal periaqueductal grey matter","volume":"85","author":"Schutz","year":"1985","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.neulet.2011.03.040_bib0115","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.lfs.2010.08.009","article-title":"Pindolol potentiates the panicolytic effect of paroxetine in the elevated T-maze","volume":"87","author":"Sela","year":"2010","journal-title":"Life Sci."},{"key":"10.1016\/j.neulet.2011.03.040_bib0120","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1002\/hup.672","article-title":"Pindolol augmentation of selective serotonin reuptake inhibitors: accounting for the variability of results of placebo-controlled double-blind studies in patients with major depression","volume":"20","author":"Segrave","year":"2005","journal-title":"Hum. Psychopharmacol."},{"key":"10.1016\/j.neulet.2011.03.040_bib0125","doi-asserted-by":"crossref","first-page":"34","DOI":"10.4088\/JCP.v66n0105","article-title":"Efficacy and tolerability of controlled-release paroxetine in the treatment of panic disorder","volume":"66","author":"Sheehan","year":"2005","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.neulet.2011.03.040_bib0130","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S0165-0327(98)00221-3","article-title":"Mechanism of action of serotonin selective reuptake inhibitors. Serotonin receptors and pathways mediate therapeutic effects and side effects","volume":"51","author":"Stahl","year":"1998","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.neulet.2011.03.040_bib0135","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/S0091-3057(99)00261-0","article-title":"Behavioral effects of acute and chronic imipramine in the elevated T-maze model of anxiety","volume":"65","author":"Teixeira","year":"2000","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neulet.2011.03.040_bib0140","series-title":"Psychopharmacology: The Fourth Generation of Progress","first-page":"1081","article-title":"Treatment-resistant depression","author":"Thase","year":"1995"},{"key":"10.1016\/j.neulet.2011.03.040_bib0145","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.4088\/JCP.v65n1010","article-title":"Effectiveness of low doses of paroxetine controlled release in the treatment of major depressive disorder","volume":"65","author":"Trivedi","year":"2004","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.neulet.2011.03.040_bib0150","doi-asserted-by":"crossref","first-page":"S257","DOI":"10.1016\/S0924-977X(98)80466-5","article-title":"Pindolol does not augment the panicolytic effects of fluvoxamine in panic disorders patients","volume":"8","author":"Van Vliet","year":"1998","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.neulet.2011.03.040_bib0155","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0091-3057(96)00451-0","article-title":"Kainate microinjection into the dorsal raphe nucleus induces 5-HT release in the amygdala and periaqueductal gray","volume":"58","author":"Viana","year":"1997","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neulet.2011.03.040_bib0160","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0014-2999(03)01970-8","article-title":"Serotonin in the dorsal periaqueductal gray modulates inhibitory avoidance and one-way escape behaviors in the elevated T-maze","volume":"473","author":"Zanoveli","year":"2003","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neulet.2011.03.040_bib0165","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1097\/01.fbp.0000179280.05654.5a","article-title":"Chronic imipramine treatment sensitizes 5-HT1A and 5-HT2A receptors in the dorsal periaqueductal gray matter: evidence from the elevated T-maze test of anxiety","volume":"16","author":"Zanoveli","year":"2005","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.neulet.2011.03.040_bib0170","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1016\/j.neuropharm.2007.01.001","article-title":"Enhanced reactivity of 5-HT1A receptors in the rat dorsal periaqueductal gray matter after chronic treatment with fluoxetine and sertraline: evidence from the elevated T-maze","volume":"52","author":"Zanoveli","year":"2007","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neulet.2011.03.040_bib0175","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1017\/S146114570999099X","article-title":"Facilitation of 5-HT1A-mediated neurotransmission in dorsal periaqueductal grey matter accounts for the panicolytic-like effect of chronic fluoxetine","volume":"13","author":"Zanoveli","year":"2010","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.neulet.2011.03.040_bib0180","doi-asserted-by":"crossref","first-page":"S81","DOI":"10.1016\/S0006-3223(00)00530-8","article-title":"Treatment with the presynaptic 5-HT1A-antagonist pindolol in patients with panic disorder","volume":"47","author":"Ziegenbein","year":"2000","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neulet.2011.03.040_bib0185","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0924-9338(02)80705-2","article-title":"Pindolol in panic disorder","volume":"17","author":"Ziegenbein","year":"2002","journal-title":"Eur. Psychiatry"},{"key":"10.1016\/j.neulet.2011.03.040_bib0190","doi-asserted-by":"crossref","first-page":"S99","DOI":"10.1016\/S0924-977X(98)80074-6","article-title":"Pindolol augmentation in treatment-resistant panic disorder and obsessive\u2013compulsive disorder","volume":"8","author":"Zohar","year":"1998","journal-title":"Eur. Neuropsychopharmacol."}],"container-title":["Neuroscience Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304394011003326?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304394011003326?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,3]],"date-time":"2018-12-03T14:50:15Z","timestamp":1543848615000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304394011003326"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,5]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,5]]}},"alternative-id":["S0304394011003326"],"URL":"https:\/\/doi.org\/10.1016\/j.neulet.2011.03.040","relation":{},"ISSN":["0304-3940"],"issn-type":[{"value":"0304-3940","type":"print"}],"subject":[],"published":{"date-parts":[[2011,5]]}}}